Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Rapid Diagnostic Testing for Influenza Market Growth (Status and Outlook) 2022-2028

  • LP 4861023
  • 110 Pages
  • February 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Rapid Diagnostic Testing for Influenza will have significant change from previous year. According to our (LP Information) latest study, the global Rapid Diagnostic Testing for Influenza market size is USD million in 2022 from USD 1040.5 million in 2021, with a change of % between 2021 and 2022. The global Rapid Diagnostic Testing for Influenza market size will reach USD 1938.4 million in 2028, growing at a CAGR of 9.3% over the analysis period.

The United States Rapid Diagnostic Testing for Influenza market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Rapid Diagnostic Testing for Influenza market, reaching US$ million by the year 2028. As for the Europe Rapid Diagnostic Testing for Influenza landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Rapid Diagnostic Testing for Influenza players cover BD, Abbot (Alere), Quidel, and Roche, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Diagnostic Testing for Influenza market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Digital RIDTs

Conventional RIDT

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospitals

POCT

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

BD

Abbot (Alere)

Quidel

Roche

Thermo Fisher Scientific

Meridian Bioscience

Analytik Jena

Princeton BioMeditech Corporation

BioMerieux

Sekisui Diagnostics

Response Biomedical

SA Scientific

DiaSorin (Focus Diagnostics)

Wondfo

Beijing Wantai Biological Pharmacy

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Rapid Diagnostic Testing for Influenza Market Size 2017-2028

2.1.2 Rapid Diagnostic Testing for Influenza Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Rapid Diagnostic Testing for Influenza Segment by Type

2.2.1 Digital RIDTs

2.2.2 Conventional RIDT

2.3 Rapid Diagnostic Testing for Influenza Market Size by Type

2.3.1 Rapid Diagnostic Testing for Influenza Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2017-2022)

2.4 Rapid Diagnostic Testing for Influenza Segment by Application

2.4.1 Hospitals

2.4.2 POCT

2.4.3 Others

2.5 Rapid Diagnostic Testing for Influenza Market Size by Application

2.5.1 Rapid Diagnostic Testing for Influenza Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2017-2022)

3 Rapid Diagnostic Testing for Influenza Market Size by Player

3.1 Rapid Diagnostic Testing for Influenza Market Size Market Share by Players

3.1.1 Global Rapid Diagnostic Testing for Influenza Revenue by Players (2020-2022)

3.1.2 Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Players (2020-2022)

3.2 Global Rapid Diagnostic Testing for Influenza Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Rapid Diagnostic Testing for Influenza by Regions

4.1 Rapid Diagnostic Testing for Influenza Market Size by Regions (2017-2022)

4.2 Americas Rapid Diagnostic Testing for Influenza Market Size Growth (2017-2022)

4.3 APAC Rapid Diagnostic Testing for Influenza Market Size Growth (2017-2022)

4.4 Europe Rapid Diagnostic Testing for Influenza Market Size Growth (2017-2022)

4.5 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Growth (2017-2022)

5 Americas

5.1 Americas Rapid Diagnostic Testing for Influenza Market Size by Country (2017-2022)

5.2 Americas Rapid Diagnostic Testing for Influenza Market Size by Type (2017-2022)

5.3 Americas Rapid Diagnostic Testing for Influenza Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Rapid Diagnostic Testing for Influenza Market Size by Region (2017-2022)

6.2 APAC Rapid Diagnostic Testing for Influenza Market Size by Type (2017-2022)

6.3 APAC Rapid Diagnostic Testing for Influenza Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Rapid Diagnostic Testing for Influenza by Country (2017-2022)

7.2 Europe Rapid Diagnostic Testing for Influenza Market Size by Type (2017-2022)

7.3 Europe Rapid Diagnostic Testing for Influenza Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Rapid Diagnostic Testing for Influenza by Region (2017-2022)

8.2 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type (2017-2022)

8.3 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Rapid Diagnostic Testing for Influenza Market Forecast

10.1 Global Rapid Diagnostic Testing for Influenza Forecast by Regions (2023-2028)

10.1.1 Global Rapid Diagnostic Testing for Influenza Forecast by Regions (2023-2028)

10.1.2 Americas Rapid Diagnostic Testing for Influenza Forecast

10.1.3 APAC Rapid Diagnostic Testing for Influenza Forecast

10.1.4 Europe Rapid Diagnostic Testing for Influenza Forecast

10.1.5 Middle East & Africa Rapid Diagnostic Testing for Influenza Forecast

10.2 Americas Rapid Diagnostic Testing for Influenza Forecast by Country (2023-2028)

10.2.1 United States Rapid Diagnostic Testing for Influenza Market Forecast

10.2.2 Canada Rapid Diagnostic Testing for Influenza Market Forecast

10.2.3 Mexico Rapid Diagnostic Testing for Influenza Market Forecast

10.2.4 Brazil Rapid Diagnostic Testing for Influenza Market Forecast

10.3 APAC Rapid Diagnostic Testing for Influenza Forecast by Region (2023-2028)

10.3.1 China Rapid Diagnostic Testing for Influenza Market Forecast

10.3.2 Japan Rapid Diagnostic Testing for Influenza Market Forecast

10.3.3 Korea Rapid Diagnostic Testing for Influenza Market Forecast

10.3.4 Southeast Asia Rapid Diagnostic Testing for Influenza Market Forecast

10.3.5 India Rapid Diagnostic Testing for Influenza Market Forecast

10.3.6 Australia Rapid Diagnostic Testing for Influenza Market Forecast

10.4 Europe Rapid Diagnostic Testing for Influenza Forecast by Country (2023-2028)

10.4.1 Germany Rapid Diagnostic Testing for Influenza Market Forecast

10.4.2 France Rapid Diagnostic Testing for Influenza Market Forecast

10.4.3 UK Rapid Diagnostic Testing for Influenza Market Forecast

10.4.4 Italy Rapid Diagnostic Testing for Influenza Market Forecast

10.4.5 Russia Rapid Diagnostic Testing for Influenza Market Forecast

10.5 Middle East & Africa Rapid Diagnostic Testing for Influenza Forecast by Region (2023-2028)

10.5.1 Egypt Rapid Diagnostic Testing for Influenza Market Forecast

10.5.2 South Africa Rapid Diagnostic Testing for Influenza Market Forecast

10.5.3 Israel Rapid Diagnostic Testing for Influenza Market Forecast

10.5.4 Turkey Rapid Diagnostic Testing for Influenza Market Forecast

10.5.5 GCC Countries Rapid Diagnostic Testing for Influenza Market Forecast

10.6 Global Rapid Diagnostic Testing for Influenza Forecast by Type (2023-2028)

10.7 Global Rapid Diagnostic Testing for Influenza Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 BD

11.1.1 BD Company Information

11.1.2 BD Rapid Diagnostic Testing for Influenza Product Offered

11.1.3 BD Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 BD Main Business Overview

11.1.5 BD Latest Developments

11.2 Abbot (Alere)

11.2.1 Abbot (Alere) Company Information

11.2.2 Abbot (Alere) Rapid Diagnostic Testing for Influenza Product Offered

11.2.3 Abbot (Alere) Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Abbot (Alere) Main Business Overview

11.2.5 Abbot (Alere) Latest Developments

11.3 Quidel

11.3.1 Quidel Company Information

11.3.2 Quidel Rapid Diagnostic Testing for Influenza Product Offered

11.3.3 Quidel Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Quidel Main Business Overview

11.3.5 Quidel Latest Developments

11.4 Roche

11.4.1 Roche Company Information

11.4.2 Roche Rapid Diagnostic Testing for Influenza Product Offered

11.4.3 Roche Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Roche Main Business Overview

11.4.5 Roche Latest Developments

11.5 Thermo Fisher Scientific

11.5.1 Thermo Fisher Scientific Company Information

11.5.2 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product Offered

11.5.3 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Thermo Fisher Scientific Main Business Overview

11.5.5 Thermo Fisher Scientific Latest Developments

11.6 Meridian Bioscience

11.6.1 Meridian Bioscience Company Information

11.6.2 Meridian Bioscience Rapid Diagnostic Testing for Influenza Product Offered

11.6.3 Meridian Bioscience Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Meridian Bioscience Main Business Overview

11.6.5 Meridian Bioscience Latest Developments

11.7 Analytik Jena

11.7.1 Analytik Jena Company Information

11.7.2 Analytik Jena Rapid Diagnostic Testing for Influenza Product Offered

11.7.3 Analytik Jena Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Analytik Jena Main Business Overview

11.7.5 Analytik Jena Latest Developments

11.8 Princeton BioMeditech Corporation

11.8.1 Princeton BioMeditech Corporation Company Information

11.8.2 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product Offered

11.8.3 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Princeton BioMeditech Corporation Main Business Overview

11.8.5 Princeton BioMeditech Corporation Latest Developments

11.9 BioMerieux

11.9.1 BioMerieux Company Information

11.9.2 BioMerieux Rapid Diagnostic Testing for Influenza Product Offered

11.9.3 BioMerieux Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 BioMerieux Main Business Overview

11.9.5 BioMerieux Latest Developments

11.10 Sekisui Diagnostics

11.10.1 Sekisui Diagnostics Company Information

11.10.2 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product Offered

11.10.3 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Sekisui Diagnostics Main Business Overview

11.10.5 Sekisui Diagnostics Latest Developments

11.11 Response Biomedical

11.11.1 Response Biomedical Company Information

11.11.2 Response Biomedical Rapid Diagnostic Testing for Influenza Product Offered

11.11.3 Response Biomedical Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Response Biomedical Main Business Overview

11.11.5 Response Biomedical Latest Developments

11.12 SA Scientific

11.12.1 SA Scientific Company Information

11.12.2 SA Scientific Rapid Diagnostic Testing for Influenza Product Offered

11.12.3 SA Scientific Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 SA Scientific Main Business Overview

11.12.5 SA Scientific Latest Developments

11.13 DiaSorin (Focus Diagnostics)

11.13.1 DiaSorin (Focus Diagnostics) Company Information

11.13.2 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Product Offered

11.13.3 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 DiaSorin (Focus Diagnostics) Main Business Overview

11.13.5 DiaSorin (Focus Diagnostics) Latest Developments

11.14 Wondfo

11.14.1 Wondfo Company Information

11.14.2 Wondfo Rapid Diagnostic Testing for Influenza Product Offered

11.14.3 Wondfo Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Wondfo Main Business Overview

11.14.5 Wondfo Latest Developments

11.15 Beijing Wantai Biological Pharmacy

11.15.1 Beijing Wantai Biological Pharmacy Company Information

11.15.2 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Product Offered

11.15.3 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Beijing Wantai Biological Pharmacy Main Business Overview

11.15.5 Beijing Wantai Biological Pharmacy Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Rapid Diagnostic Testing for Influenza Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Digital RIDTs

Table 3. Major Players of Conventional RIDT

Table 4. Rapid Diagnostic Testing for Influenza Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Rapid Diagnostic Testing for Influenza Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2017-2022)

Table 7. Rapid Diagnostic Testing for Influenza Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Rapid Diagnostic Testing for Influenza Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2017-2022)

Table 10. Global Rapid Diagnostic Testing for Influenza Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Player (2020-2022)

Table 12. Rapid Diagnostic Testing for Influenza Key Players Head office and Products Offered

Table 13. Rapid Diagnostic Testing for Influenza Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Rapid Diagnostic Testing for Influenza Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Regions (2017-2022)

Table 18. Americas Rapid Diagnostic Testing for Influenza Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Rapid Diagnostic Testing for Influenza Market Size Market Share by Country (2017-2022)

Table 20. Americas Rapid Diagnostic Testing for Influenza Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2017-2022)

Table 22. Americas Rapid Diagnostic Testing for Influenza Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2017-2022)

Table 24. APAC Rapid Diagnostic Testing for Influenza Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Rapid Diagnostic Testing for Influenza Market Size Market Share by Region (2017-2022)

Table 26. APAC Rapid Diagnostic Testing for Influenza Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2017-2022)

Table 28. APAC Rapid Diagnostic Testing for Influenza Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2017-2022)

Table 30. Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Rapid Diagnostic Testing for Influenza Market Size Market Share by Country (2017-2022)

Table 32. Europe Rapid Diagnostic Testing for Influenza Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2017-2022)

Table 34. Europe Rapid Diagnostic Testing for Influenza Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Rapid Diagnostic Testing for Influenza

Table 43. Key Market Challenges & Risks of Rapid Diagnostic Testing for Influenza

Table 44. Key Industry Trends of Rapid Diagnostic Testing for Influenza

Table 45. Global Rapid Diagnostic Testing for Influenza Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Rapid Diagnostic Testing for Influenza Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Rapid Diagnostic Testing for Influenza Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Rapid Diagnostic Testing for Influenza Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Rapid Diagnostic Testing for Influenza Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Rapid Diagnostic Testing for Influenza Market Size Market Share Forecast by Application (2023-2028)

Table 51. BD Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors

Table 52. BD Rapid Diagnostic Testing for Influenza Product Offered

Table 53. BD Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. BD Main Business

Table 55. BD Latest Developments

Table 56. Abbot (Alere) Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors

Table 57. Abbot (Alere) Rapid Diagnostic Testing for Influenza Product Offered

Table 58. Abbot (Alere) Main Business

Table 59. Abbot (Alere) Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Abbot (Alere) Latest Developments

Table 61. Quidel Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors

Table 62. Quidel Rapid Diagnostic Testing for Influenza Product Offered

Table 63. Quidel Main Business

Table 64. Quidel Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Quidel Latest Developments

Table 66. Roche Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors

Table 67. Roche Rapid Diagnostic Testing for Influenza Product Offered

Table 68. Roche Main Business

Table 69. Roche Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Roche Latest Developments

Table 71. Thermo Fisher Scientific Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors

Table 72. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product Offered

Table 73. Thermo Fisher Scientific Main Business

Table 74. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Thermo Fisher Scientific Latest Developments

Table 76. Meridian Bioscience Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors

Table 77. Meridian Bioscience Rapid Diagnostic Testing for Influenza Product Offered

Table 78. Meridian Bioscience Main Business

Table 79. Meridian Bioscience Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Meridian Bioscience Latest Developments

Table 81. Analytik Jena Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors

Table 82. Analytik Jena Rapid Diagnostic Testing for Influenza Product Offered

Table 83. Analytik Jena Main Business

Table 84. Analytik Jena Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Analytik Jena Latest Developments

Table 86. Princeton BioMeditech Corporation Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors

Table 87. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product Offered

Table 88. Princeton BioMeditech Corporation Main Business

Table 89. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Princeton BioMeditech Corporation Latest Developments

Table 91. BioMerieux Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors

Table 92. BioMerieux Rapid Diagnostic Testing for Influenza Product Offered

Table 93. BioMerieux Main Business

Table 94. BioMerieux Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. BioMerieux Latest Developments

Table 96. Sekisui Diagnostics Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors

Table 97. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product Offered

Table 98. Sekisui Diagnostics Main Business

Table 99. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Sekisui Diagnostics Latest Developments

Table 101. Response Biomedical Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors

Table 102. Response Biomedical Rapid Diagnostic Testing for Influenza Product Offered

Table 103. Response Biomedical Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Response Biomedical Main Business

Table 105. Response Biomedical Latest Developments

Table 106. SA Scientific Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors

Table 107. SA Scientific Rapid Diagnostic Testing for Influenza Product Offered

Table 108. SA Scientific Main Business

Table 109. SA Scientific Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. SA Scientific Latest Developments

Table 111. DiaSorin (Focus Diagnostics) Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors

Table 112. DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Product Offered

Table 113. DiaSorin (Focus Diagnostics) Main Business

Table 114. DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. DiaSorin (Focus Diagnostics) Latest Developments

Table 116. Wondfo Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors

Table 117. Wondfo Rapid Diagnostic Testing for Influenza Product Offered

Table 118. Wondfo Main Business

Table 119. Wondfo Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Wondfo Latest Developments

Table 121. Beijing Wantai Biological Pharmacy Details, Company Type, Rapid Diagnostic Testing for Influenza Area Served and Its Competitors

Table 122. Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Product Offered

Table 123. Beijing Wantai Biological Pharmacy Main Business

Table 124. Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 125. Beijing Wantai Biological Pharmacy Latest Developments

List of Figures

Figure 1. Rapid Diagnostic Testing for Influenza Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Rapid Diagnostic Testing for Influenza Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Type in 2021

Figure 7. Rapid Diagnostic Testing for Influenza in Hospitals

Figure 8. Global Rapid Diagnostic Testing for Influenza Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Rapid Diagnostic Testing for Influenza in POCT

Figure 10. Global Rapid Diagnostic Testing for Influenza Market: POCT (2017-2022) & ($ Millions)

Figure 11. Rapid Diagnostic Testing for Influenza in Others

Figure 12. Global Rapid Diagnostic Testing for Influenza Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Application in 2021

Figure 14. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Player in 2021

Figure 15. Global Rapid Diagnostic Testing for Influenza Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Rapid Diagnostic Testing for Influenza Market Size 2017-2022 ($ Millions)

Figure 17. APAC Rapid Diagnostic Testing for Influenza Market Size 2017-2022 ($ Millions)

Figure 18. Europe Rapid Diagnostic Testing for Influenza Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size 2017-2022 ($ Millions)

Figure 20. Americas Rapid Diagnostic Testing for Influenza Value Market Share by Country in 2021

Figure 21. Americas Rapid Diagnostic Testing for Influenza Consumption Market Share by Type in 2021

Figure 22. Americas Rapid Diagnostic Testing for Influenza Market Size Market Share by Application in 2021

Figure 23. United States Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Rapid Diagnostic Testing for Influenza Market Size Market Share by Region in 2021

Figure 28. APAC Rapid Diagnostic Testing for Influenza Market Size Market Share by Application in 2021

Figure 29. China Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Rapid Diagnostic Testing for Influenza Market Size Market Share by Country in 2021

Figure 36. Europe Rapid Diagnostic Testing for Influenza Market Size Market Share by Type in 2021

Figure 37. Europe Rapid Diagnostic Testing for Influenza Market Size Market Share by Application in 2021

Figure 38. Germany Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Market Share by Application in 2021

Figure 46. Egypt Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Rapid Diagnostic Testing for Influenza Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 52. APAC Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 53. Europe Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 55. United States Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 56. Canada Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 59. China Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 60. Japan Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 61. Korea Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 63. India Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 64. Australia Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 65. Germany Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 66. France Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 67. UK Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 68. Italy Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 69. Russia Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 70. Spain Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 73. Israel Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Rapid Diagnostic Testing for Influenza Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450